MicroRNAs as Potential Targets for Treatment of Osteoclast-Related Diseases

Author(s): Haowei Li, Zanjing Zhai, Xinhua Qu, Jiake Xu, An Qin*, Kerong Dai*

Journal Name: Current Drug Targets

Volume 19 , Issue 5 , 2018

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: Understanding the roles of miRNAs in osteoclasts has great potential in the diagnosis and treatment of osteolytic diseases.

Objective: The purpose of this paper was to describe the current knowledge of miRNA biogenesis and summarize recent work on the roles of miRNAs in osteoclasts.

Results: There is accumulating evidence to indicate that miRNAs constitute a novel and efficient mechanism for the regulation of gene expression.

Conclusion: Untangling the role that miRNAs play in osteoclastogenesis will illuminate new strategies and specific drug targets for the treatment of osteolytic diseases. Many questions remain, but an in-depth comprehension of the network and kinetics of miRNAs expression, and their connection with cognate genes will not be trivial, but fruitful.

Keywords: Drug targets, miRNAs, osteoclasts, osteolytic diseases, bone homeostasis, biogenesis.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Published on: 19 March, 2018
Page: [422 - 431]
Pages: 10
DOI: 10.2174/1389450117666160502144329
Price: $65

Article Metrics

PDF: 58
PRC: 1